Transwell assay showing increased invasion in SNB19 and U251 glioma cells transfected with FAM111B-overexpressing lentivirus, compared to controls. Magnification ×20 Study shows FAM111B overexpression ...

Genprex, Inc. ("Genprex" or the "Company") , a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced that it has been ...

Biotium, a leading provider of fluorescent reagents for life science research, has expanded its trusted Cheetah™ Taq DNA Polymerase line with two powerful new formulations: Cheetah™ FLEX ...

A study finds DNA damage and threats to cellular health with occupational exposure of farmers and farmworkers.

ASCO 2025 will showcase cutting-edge advancements in precision medicine, artificial intelligence, and biomarker-driven ...

Based on whole-genome sequencing (WGS), the investigational test detected circulating tumor (ct)DNA with a sensitivity and ...

Cell.Ai, a precision oncology company developing advanced cell and molecular profiling platforms, announced the successful completion of a CLIA-grade analytical validation study of its OncoIncytes ...

It’s a moment of concern that no cat parent wants – when you scoop the litter box, and something just looks… off. Perhaps ...

Commercialization building with large pharma contracts secured Further progress on next generation sequencing assays for DNA ...

During a live event, Deborah Wong, MD, PhD, discussed the role of EBV and challenges in nasopharyngeal cancer diagnosis with ...

In addition to the MRD oral abstract, additional research highlights include: “We have an exciting, diverse, and sizable slate of oncology results being presented at ASCO this year, where each ...

The Kiwi medical devices outfit has upped its full year revenue to a record NZ$2.2 billion and guides to a stronger result this year.